Summary
The effect of repeated treatment (5 and 10 mg/kg,po, twice daily, 14 days) with sertraline and citalopram (antidepressants which selectively inhibit the reuptake of 5-hydroxytryptamine (5-HT)) on the responsiveness of different 5-HT receptors to their agonists, was examined in rats and mice. Sertraline and citalopram (both at a dose 5 and 10 mg/kg) antagonized (the first one more potently) the hypothermia induced in mice by 8-OH-DPAT (a 5-HT1A agonist), but not the behavioural syndrome induced in rats by this substance. The m-chlorophenylpiperazine-induced hypothermia in mice (a 5-HT1B effect) was increased by sertraline and citalopram (only in a dose of 10 mg/kg). Both antidepressants, given repeatedly (as well acutely) attenuated exploratory hypoactivity induced in rats by m-chlorophenylpiperazine (a 5-HT1C effect). L-5-HTP-induced head twitches in mice (5-HT2 effect) were antagonized dose-dependently by both repeated sertraline and citalopram. Both antidepressants (citalopram only in higher dose) reduced the fenfluramine-induced hyperthermia in rats (5-HT2 effect).
The results indicate that sertraline and citalopram given repeatedly decrease the responsiveness of 5-HT1A (presynaptic) and 5-HT2 receptors but increase the responsiveness of 5-HT1B receptors to respective agonists.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arnt J, Fredricson O, Hyttel J, Olsen R (1984) Changes in rat dopamine and serotonin function in vivo after prolongated administration of the specific 5-HT uptake inhibitor, citalopram. Psychopharmacology 84: 457–465
Arnt J, Hyttel J, Larsen JJ (1984) The citalopram/5-HTP-induced shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmitters. Acta Pharmacol Toxicol 55: 363–372
Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemis DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25: 563–576
Byerley WF, McConnell EJ, McCabe RT, Dawson TM, Grosser BI, Wamsley JK (1987) Chronic administration of sertraline, a selective serotonin uptake inhibitor, decreased the density of beta-adrenergic receptors in rat fronto-parietal cortex. Brain Res 421: 377–381
Chaput Y, De Montigny C, Blier P (1986) Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 333: 342–348
Cervo L, Grignaschi G, Rossi C, Samanin R (1991) Role of central serotonergic neurons in the effect of sertraline in rats in the forced swimming test. Eur J Pharmacol 196: 217–222
Corne SJ, Pickering RW, Warner BT (1963) A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. Br J Pharmacol 20: 106–120
Fozard JR (1987) 5-HT: the enigma variations. Trends Pharmacol Sci 8: 501–506
Goodwin GM, Green AR (1985) A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors. Br J Pharmacol 84: 743–753
Goodwin GM, De Souza RJ, Green AR (1985) Presynaptic serotonin receptor — mediated response in mice attenuated by antidepressant drugs and electroconvulsive shock. Nature 317: 531–533
Goodwin GM, De Souza RJ, Green AR, Heal DJ (1987) The pharmacology of the behavioural and hypothermic responses of rats of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Psychopharmacology 91: 506–511
Hensler JG, Kovachich GB, Frazer A (1991) A quantitative autoradiographic study of serotonin 1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropharmacology 25: 563–576
Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikstrom H, Nilsson JLG (1982) 8-Hydroxy-2-(di-n-propylamino)-tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity. J Neural Transm 55: 169–188
Hoyer D, Waeber C, Pazos A, Probst A, Palacios JM (1986) Sertonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res 376: 85–90
Hyttel J (1982) Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 6: 277–295
Hyttel J, Fredricson O, Arnt J (1984) Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibition, citalopram. Psychopharmacology 83: 20–27
Janssen PAJ, Jageneau AHM, Schellkens KHL (1960) Chemistry and pharmacology of compounds releated to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenoe. Part IV. Influence of haloperidol (R-1625) and of chloropromazine on the behaviour of rats in an unfamiliar “open field” situation. Psychopharmacologia 1: 389–392
Kennett GA, Curzon G (1988) Evidence that m-CPP may have behavioral effects mediated by central 5-HT1C receptors. Br J Pharmacol 94: 137–147
Kłodzińska A, Jaros T, Chojnacka-Wójcik E, Maj J (1989) Exploratory hypoactivity induced by m-trifluoromethylphenylopiperazine (TFMPP) and m-chlorophenylpiperazine (m-CPP). J Neural Transm [P-D Sect] 1: 207–218
Koe BK, Wiessman A, Welch WM, Browne RG (1983) Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin. J Pharmacol Exp Ther 245: 969–974
Koe BK, Koch SW, Lebel LA, Minor KW, Page MG (1987) Sertraline, a selective inhibitor of serotonin uptake of rat brain. Eur J Pharmacol 141: 187–194
Maj J, Chojnacka-Wójcik E, Klodzińska A, Dereń A, Moryl E (1988) Hypothermia induced by m-trifluoromethylphenylopiperazine or m-chlorophenylpiperazine: an effect mediated by 5-HT1B receptors? J Neural Transm 70: 1–17
Middlemiss DN, Fozard JR (1983) 8-Hydroxy-2-(di-n-propylamino)tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmacol 90: 151–153
Mol F, Tulp MThM, Schipper J, van Charldorp KJ (1990) Molecular pharmacology of 5-HT-uptake inhibitors. In: XIth International Congress of Pharmacology. Amsterdam, July 2–6, 1990
Moser PC (1991) The effect of putative 5-HT1A receptor antagonists on 8-OH-DPAT-induced hypothermia in rats and mice. Eur J Pharmacol 193: 165–172
Pawłowski L (1981) Different action of 5-hydroxytryptamine (5-HT) uptake inhibitors on fenfluramine — but not p-chloroamphetamine-induced hyperthermia in rats. J Pharm Pharmacol 74: 161–165
Peroutka SJ (1985) Selective labeling of 5-HT1A and 5-HT1B binding sites in bovine brain. Brain Res 344: 167–171
Reimherr FW, Byerley WF, Ward MF, Lebegue BJ (1988) Sertraline, a selective inhibitor of serotonin uptake, for the treatment of outpatients with major depressive disorder. Psychopharmacol Bull 24: 200–205
Sulpizio A, Fowler PJ, Macko E (1978) Antagonism of fenlfuramine-induced hypothermia: a measure of central serotonin inhibition. Life Sci 22: 1439–1446
Sanders-Bush E, Breeding M, Knoth K, Toutsumi M (1989) Sertraline-induced desensitization of the serotonin 5-HT2 receptor transmembrane signaling system. Psychopharmacology 99: 64–69
Tricklebank MD, Forler C, Fozard JR (1985) The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic system in the behavioral response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur J Pharmacol 106: 272–282
Yamada Y, Sugimoto Y, Horisaka K (1988) The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice. Eur J Pharmacol 154: 299–304
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maj, J., Moryl, E. Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations. J. Neural Transmission 88, 143–156 (1992). https://doi.org/10.1007/BF01244819
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01244819